Dr. Agarwal's Health Care Limited
NSE: AGARWALEYE · Unclassified
Ask the data
Instant answers about Dr. Agarwal's Health Care Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY25 | FY26 | |
|---|---|---|
| Revenue | 1,711 | 2,080 |
| EBITDA | 456 | 570 |
| Operating margin | 26.7% | 27.4% |
| Interest | 109 | 90 |
| Depreciation | 231 | 276 |
| Profit before tax | 160 | 249 |
| Tax | 50 | 80 |
| Net profit | 83 | 133 |
| EPS ₹ | 2.80 | 4.21 |
| Operating cash flow | 360 | 519 |
| Capex | 321 | 461 |
| Dividend paid | 1 | 1 |
| Total assets | 3,672 | 3,942 |
| Equity | 1,867 | 2,025 |
Quarterly performance
last 8 quarters · ₹ crore| DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 431 | 460 | 487 | 499 | 530 | 564 | 614 | 655 |
| Operating profit | 115 | 131 | 128 | 136 | 144 | 161 | 170 | 176 |
| Operating margin | 26.7% | 28.5% | 26.2% | 27.3% | 27.2% | 28.6% | 27.8% | 26.8% |
| Other income | 13 | 15 | 13 | 8 | 11 | 13 | 6 | 10 |
| Interest | 28 | 25 | 25 | 23 | 21 | 22 | 23 | 23 |
| Depreciation | 58 | 60 | 63 | 68 | 69 | 77 | 78 | 83 |
| Profit before tax | 41 | 59 | 54 | 54 | 65 | 77 | 75 | 80 |
| Tax | 13 | 16 | 16 | 17 | 21 | 27 | 20 | 23 |
| Net profit | 22 | 33 | 30 | 30 | 34 | 40 | 45 | 55 |
| EPS ₹ | 0.73 | 1.04 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 | 1.65 |
| Revenue YoY | — | — | — | — | 23.0% | 22.6% | 26.0% | 31.4% |
| Profit YoY | — | — | — | — | 51.0% | 21.9% | 50.5% | 84.4% |
Returns & margins
trailing-twelve-month, per quarter| SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|
| ROE | 5.9% | 6.5% | 6.6% | 7.3% | 7.8% |
| ROCE | 14.6% | 15.3% | 15.5% | 16.5% | 15.8% |
| Net margin | 6.1% | 6.4% | 6.4% | 6.7% | 7.3% |
| EBITDA margin | 27.2% | 27.3% | 27.4% | 27.7% | 27.6% |
| Debt / equity | 0.09 | 0.09 | 0.08 | 0.08 | 0.09 |
| Interest coverage | 3.06 | 3.47 | 3.75 | 4.03 | 4.31 |
| Asset turnover | 0.50 | 0.52 | 0.53 | 0.56 | 0.56 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '25 | SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|---|
| Share capital | 32 | 32 | 32 | 32 |
| Other equity / reserves | 1,835 | 1,899 | 1,994 | 2,206 |
| Total equity | 1,867 | 1,931 | 2,025 | 2,237 |
| Borrowings | 247 | 180 | 157 | 201 |
| Current liabilities | 478 | 459 | 461 | 508 |
| Non-current liabilities | 1,267 | 1,308 | 1,361 | 1,463 |
| Total assets | 3,672 | 3,786 | 3,942 | 4,207 |
| Property, plant & equipment | 708 | 1,546 | 926 | 1,096 |
| Capital work-in-progress | 144 | 163 | 234 | 250 |
| Investments | 264 | 208 | 152 | 71 |
| Inventories | 80 | 78 | 94 | 108 |
| Receivables | 124 | 138 | 161 | 187 |
| Cash & equivalents | 104 | 98 | 91 | 101 |
Cash flow
annual · ₹ crore · line = free cash flow| FY25 | FY26 | |
|---|---|---|
| Cash from operations | 360 | 519 |
| Cash from investing | -750 | -308 |
| Cash from financing | 382 | -220 |
| Capex | 321 | 461 |
| Free cash flow | 39 | 58 |
| Dividends paid | 1 | 1 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Dr. Agarwal's Health Care Limited | 16,368 | 516.35 | 94.4 | 7.32 | 7.8% |
StoxGud checklist: Neutral setup · 6/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Dr. Agarwal's Health Care Limited?
Dr. Agarwal's Health Care Limited (AGARWALEYE) closed at ₹516.35 on NSE on 06 Nov 2026.
What is the market cap of Dr. Agarwal's Health Care Limited?
₹16,368 crore at the latest close.
What is the P/E ratio of Dr. Agarwal's Health Care Limited?
94.4, on trailing-twelve-month earnings from its filings.
How fast is Dr. Agarwal's Health Care Limited growing?
Dr. Agarwal's Health Care Limited: Latest-quarter revenue is up 31.4% year on year, profit up 84.4%.
How profitable is Dr. Agarwal's Health Care Limited?
On a trailing-twelve-month basis return on equity is 7.8%, return on capital employed 15.8%, operating margin 27.6%, net margin 7.3%.
How much debt does Dr. Agarwal's Health Care Limited have?
Dr. Agarwal's Health Care Limited is lightly geared: debt to equity is 0.09 with borrowings of ₹201 cr against cash of ₹101 cr (balance sheet of 2026-09-30). Operating profit covers interest 4.3 times.
Financials parsed from Dr. Agarwal's Health Care Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '24, annual from FY25, balance sheet from Mar '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.